NEW YORK, Aug. 30, 2016 -- People across the world are stopping the hands of time with the help of a very popular injectable. Botox, or botulinum toxin, remains a household name as the single most popular drug in the field of aesthetics. In 2015, over 4.5 million injections were performed worldwide, with women taking the top spot.
From women (and, increasingly, men) this injectable earns the top spot as the most chosen non-surgical procedure, evidenced by the latest results of the International Society of Aesthetic Plastic Surgery (ISAPS) Global Survey. Botox makes up 38.4% of non-surgical procedures overall.
Women make up the majority with 4,003,837, or 86.5% of those electing the injections, and men claim 623,914, or 13.5%. The United States takes the top spot with 1,141,595 injections, followed by Brazil with 359,865.
“We’re seeing more and more applications of Botox across the world,” notes Susumu Takayanagi, MD, President of ISAPS. “The fact that an injectable can be used to prevent wrinkles is truly extraordinary, and the public is responding. Not only does this procedure require little to no downtime, but the results are immediate. Women and men see Botox as the first step in preserving a youthful look.” The results are available on the ISAPS website, http://www.isaps.org, in the News section, and will be discussed at the global Congress in Kyoto, Japan, October 23–27, 2016.
Because of it’s efficacy at reducing “dynamic” lines and preventing them from forming, people are opting for Botox to literally stop wrinkles in their tracks. This “no guilt” option that temporarily freezes facial muscles is increasingly chosen as a wrinkle releaser. In addition, Botox has FDA approval for treating migraine pain and urinary incontinence, and is gaining approval to treat other bladder-related issues. Because the effects are temporary, people are on regular regimes with their practitioners, helping to boost the numbers.
This collection of information of surgical and non-surgical treatments from 2015 was tabulated from a questionnaire sent to approximately 35,000 plastic surgeons in the ISAPS database. ISAPS is the only organization that collects this type of data on a global scale and the study is viewed as a valuable resource in the field. The International Survey on Aesthetic/Cosmetic Procedures Performed in 2015 was compiled, tabulated and analyzed by Industry Insights, Inc., http://www.industryinsights.com, an independent research firm based in Columbus, OH.
About ISAPS:
The International Society of Aesthetic Plastic Surgery is the premier global organization for board certified plastic surgeons. Regarded as the leading global educator in aesthetic procedures, ISAPS offers its more than 3,200 members in 103 countries over 30 courses, workshops and symposia each year, conducted by a world-class faculty, with the primary goal of teaching aesthetic best practices and ensuring patient safety. Through its rigorous membership screening, ISAPS is a guardian of patient safety internationally, making it the patient’s global resource to find qualified and experienced aesthetic plastic surgeons.
Media Contact: Julie Guest, ISAPS Chief Marketing Officer [email protected] 1-844-867-3621


Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 



